Product Images Atorvastatin Calcium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Atorvastatin Calcium NDC 53002-2335 by Rpk Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure - atorvastatin calcium figure 1
Figure - atorvastatin calcium figure 2
This appears to be a graph or chart related to the cumulative hazard of a placebo versus atorvastatin, a drug used to lower cholesterol. The hazard percentage is displayed on the y-axis and the time to the first primary endpoint is shown on the x-axis over a period of four years. The results reveal a significant reduction in hazard for those taking atorvastatin compared to a placebo.*
Figure - atorvastatin calcium figure 3
This is a statistical data presentation showing the percentage of subjects who experienced an event after taking Atorvastatin 10 mg and 80 mg. The results indicate that the latter was associated with a lower hazard ratio (0.78) and a smaller p-value (0.0002). The graph shows the time in years for the first major cardiovascular endpoint. There is no information to specify the nature of the events or the size and characteristics of the subjects studied.*
Chemical Structure - atorvastatin calcium structure
Label Image - lbl530022335
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.